不用本金就能赚钱的方法

来宝网Logo

热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

现在位置不用本金就能赚钱的方法>技术资料不用本金就能赚钱的方法>行业动态>公司动态>IntegenX 收购GenVault

IntegenX 收购GenVault

互联网2011年2月9日 14:01 点击:1755

美国IntegenX

IntegenX 收购GenVault

IntegenX Acquires GenVault, Raises $15.6M

 

NEW YORK (GenomeWeb News) – Sample preparation firm IntegenX today said that it has acquired biosample storage firm GenVault. It also announced it has raised $15.6 million in a financing round.

Stevan Jovanovich, president and CEO of IntegenX, declined to disclose the terms of the deal but said the purchase moves the company further upstream in the sequencing market.

GenVault started out as a biobanking firm with robotic systems handling millions of samples. "That business model really didn't work out — the market didn't develop as quickly as they hoped for," Jovanovich told GenomeWeb Daily News.

Along the way, though, the company developed the GenTegra DNA technology for stabilizing DNA biosamples with antimicrobial activity for dry, room temperature transport and biobanking.

As IntegenX has developed sample-to-answer applications, the GenTegra product line "will increase the quality and value of data produced by IntegenX's integrated sample preparation systems," the company said in a statement.

Howard Goldstein, executive vice president for commercial affairs at IntegenX, added that as next-generation sequencing becomes more mainstream, one issue that is becoming increasingly pervasive is the stability of biosamples. The GenTegra products seek to address this.

"The reality is there hasn't been a good approach to stabilizing these samples and most of the instrumentation companies … have not really paid any attention to this," he told GWDN.

Based in Carlsbad, Calif., GenVault offered storage and management services for biosamples. Its services were mostly for DNA and RNA, but it has been developing technology directed at proteins. That development work will continue, Jovanovich said.

不用本金就能赚钱的方法GenVault is now a subsidiary of IntegenX and will remain based in Carlsbad, Jovanovich said. The deal closed on Jan. 31.

Eric Holmlin, who had been GenVault's president and CEO, was named today to those posts at genomics firm BioNanomatrix.

不用本金就能赚钱的方法In addition to the acquisition, IntegenX, based in Pleasanton, Calif., announced the close of a $15.6 million financing round, led by Domain Associates along with other existing investors, such as Rona Syndicates and In-Q-Tel.

不用本金就能赚钱的方法GenVault investors QuestMark Partners, Cross Creek Partners, and Greenspring Associates also are now investors in IntegenX.

The funds will be used to commercialize the Apollo 324 System for next-gen sequencing library preparation, development of the Apollo 200 RapidHit System for DNA-based human identification, and worldwide marketing of the GenTegra product line.

IntegenX was formerly called Microchip Biotechnologies. In late 2009, it raised $18.1 million in a Series B round.

(来源: 互联网 )


全年征稿 / 资讯合作

联系邮箱:kefu@strauss-usa.com不用本金就能赚钱的方法

BANQUANYUMIANZESHENGMING

  • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://strauss-usa.com,违反者本网将追究相关法律责任。
  • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
  • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。


湖南快乐十分 湖南快乐十分 福建快3走势图0 福建快3走势图 河南快3走势图 河南快3走势图 广东11选5开奖结果 福建11选5走势图